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The E3 ubiquitin ligase Pellino can be activated by phosphorylation
in vitro, catalyzed by IL-1 receptor-associated kinase 1 (IRAK1) or
IRAK4. Here, we show that phosphorylation enhances the E3 ligase
activity of Pellino 1 similarly with any of several E2-conjugating
enzymes (Ubc13-Uev1a, UbcH4, or UbcH5a/5b) and identify 7
amino acid residues in Pellino 1 whose phosphorylation is critical
for activation. Five of these sites are clustered between residues 76
and 86 (Ser-76, Ser-78, Thr-80, Ser-82, and Thr-86) and decorate a
region of antiparallel -sheet, termed the ‘‘wing,’’ which is an
appendage of the forkhead-associated domain that is thought to
interact with IRAK1. The other 2 sites are located at Thr-288 and
Ser-293, just N-terminal to the RING-like domain that carries the E3
ligase activity. Unusually, the full activation of Pellino 1 can be
achieved by phosphorylating any one of several different sites
(Ser-76, Thr-86, Thr-288, or Ser-293) or a combination of other sites
(Ser-78, Thr-80, and Ser-82). These observations imply that dephos-
phorylation of multiple sites is required to inactivate Pellino 1,
which could be a device for prolonging Pellino’s E3 ubiquitin ligase
activity in vivo.
Toll-like receptor  innate immunity  Lysine63-linked polyubiquitination
During infection by bacteria, bacterial products engage Toll-like receptors (TLRs) in immune cells, triggering the acti-
vation of signaling pathways that lead to the production of
proinflammatory cytokines, chemokines, and interferons. Sig-
naling via all TLRs (except TLR3) or the receptor for the
proinflammatory cytokine IL-1 leads to the recruitment of
proteins, such as myeloid differentation factor 88 (MyD88) (1, 2)
and the serine/threonine-specific protein kinases IL-1 receptor-
associated protein kinase 1 (IRAK1) and IRAK4 (3, 4). IRAK4
activates IRAK1, which is followed by the autophosphorylation
of IRAK1 at several sites (5), its release from MyD88 (6), and
its association with an E3 ubiquitin ligase, termed TNF receptor-
associated factor 6 (TRAF6) (7) with which it propagates the
signal.
Signaling by the IRAK1 (8, 9) and TRAF6 (10, 11) involves
the Lys-63-linked polyubiquitination of both proteins. The IL-
1-stimulated polyubiquitination of IRAK1 was first described
10 years ago (12) and initially thought to be a Lys-48-linked
polyubiquitination event that led to the proteasomal degradation
of IRAK1, explaining the rapid disappearance of IRAK1 under
these conditions. However, more recently, we (8) and others (9,
13) established, through the use of ubiquitin mutants, Lys-63-
linked polyubiquitin-binding proteins, and antibodies that rec-
ognize Lys-63-linked polyubiquitin chains specifically, that IL-1
stimulates the rapid Lys-63-linked polyubiquitination of IRAK1.
Moreover, we showed that incubation with proteasomal inhib-
itors did not enhance the levels of endogenous polyubiquitinated
IRAK1 nor did it prevent the IL-1-stimulated disappearance of
unmodified IRAK1 (8). Indeed, the IL-1 induced ‘‘disappear-
ance’’ of IRAK1 was reported not to be caused by proteolytic
destruction at all, but simply to result from conversion to a
variety of phosphorylated and polyubiquitinated species, as
demonstrated by the regeneration of unmodified IRAK1 upon
treatment of cell extracts with a protein phosphatase and a
deubiquitinase (9).
The Lys-63-linked polyubiquitination of IRAK1 was found to
be critical for the activation of the transcription factor NF-B,
probably by recruiting the NEMO-IKK/ complex (14, 15) and
inducing conformational changes (16) that facilitate its activa-
tion by TRAF6-associated TAK1 (10, 11, 17). However, a major
unresolved question is how IL-1 or TLR agonists stimulate the
formation of K63-linked TRAF6 and K63–pUb–IRAK1. Iso-
forms of Pellino, which were shown some years ago to interact
with IRAK1 and IRAK4 (18–22), were recently reported to be
E3 ubiquitin ligases (23–25). Moreover, we showed that Pellino
isoforms only became competent to form K63–pUb chains after
phosphorylation by IRAK1 or IRAK4 in vitro, an effect re-
versed by dephosphorylation (24). The cotransfection of vectors
encoding wild-type IRAK1 and wild-type Pellino 2 induced the
phosphorylation of Pellino 2 and the formation of K63–pUb–
IRAK1 in cells. In contrast, transfection of wild-type IRAK1
and an E3 ligase-deficient mutant of Pellino induced the phos-
phorylation of Pellino 2 but not the formation of K63–pUb–
IRAK1, whereas cotransfection of a catalytically-inactive mu-
tant of IRAK1 with wild-type Pellino 2 did not induce the
phosphorylation of Pellino 2 or the formation of K63–pUb–
IRAK1 (24). These observations were consistent with the notion
that, at least in cotransfection experiments, IRAK1 catalyzes the
phosphorylation and activation of Pellino 2, which then polyu-
biquitinates IRAK1. This mechanism can potentially explain
how IL-1 and TLR agonists stimulate the formation of K63–
pUb–IRAK1 in cells. However, when incubated in vitro with the
E2-conjugating enzyme Ubc13–Uev1a, IRAK1-activated Pel-
lino 1 mediates the formation of free Lys-63-linked polyubiquitin
chains that are not linked to either IRAK1 or Pellino 1 (24). This
result suggests that the polyubiquitination of IRAK1 may be a
2-step process. For example, Pellino may first combine with an
E2 distinct from Ubc13–Uev1a to monoubiqutinate IRAK1 and
then with Ubc13–Uev1a to produce Lys-63-linked polyubiquiti-
nated IRAK1.
To investigate whether IL-1 induces the phosphorylation of
Pellino isoforms in vivo, it is first necessary to identify the amino
acid residues phosphorylated by IRAK1 and IRAK4 in vitro and
determine which phosphorylation sites are critical for activation
Author contributions: H.S. and P.C. designed research; H.S. performed research; M.P.,
D.G.C., F.V., and E.C. contributed new reagents/analytic tools; H.S., D.G.C., F.V., and E.C.
analyzed data; and H.S. and P.C. wrote the paper.
The authors declare no conflict of interest.
Freely available online through the PNAS open access option.
1To whom correspondence should be addressed. E-mail: p.cohen@dundee.ac.uk.
This article contains supporting information online at www.pnas.org/cgi/content/full/
0900774106/DCSupplemental.
4584–4590  PNAS  March 24, 2009  vol. 106  no. 12 www.pnas.orgcgidoi10.1073pnas.0900774106
of Pellino’s E3 ligase activity. Here, we show that Pellino is
phosphorylated at multiple sites by IRAK1 and IRAK4 and that
activation can be achieved by phosphorylating any one of several
sites or a combination of other sites. These observations imply
that dephosphorylation of multiple sites is required to inactivate
Pellino 1, which could be a device for prolonging Pellino’s E3
ubiquitin ligase activity in vivo.
Results
IRAK-Catalyzed Activation of Pellino 1 Requires Phosphorylation of
Pellino 1. The E3 ligase activity of Pellino isoforms is greatly
enhanced by phosphorylation catalyzed by IRAK1 or IRAK4 in
vitro, an effect reversed by treatment with a protein phosphatase
(24). These findings suggested but did not prove that activation
had resulted from the phosphorylation of Pellino 1. In particular,
it remained possible that activation was triggered by the auto-
phosphorylation of IRAK1 and/or IRAK4, which then bound to
Pellino, inducing a conformational change that activated its
latent E3 ligase activity. To distinguish between these possibil-
ities, we compared the activity of a phosphorylated IRAK1–
unphosphorylated Pellino 1 complex with a phosphorylated
IRAK1–phosphorylated Pellino 1 complex. These experiments
demonstrated that the phosphorylated IRAK1–unphosphory-
lated Pellino 1 complex had the same activity as unphosphory-
lated Pellino 1 when assayed with Ubc13–Uev1a as the E2-
conjugating enzyme (Fig. 1A), demonstrating that the
autophosphorylation of IRAK1 per se was not sufficient to
induce the activation of unphosphorylated Pellino 1 via a
protein–protein interaction. We also found that phosphorylated
Pellino 1 remained fully active when freed from its activator
IRAK4, again showing that phosphorylation of Pellino 1 is
required for activation (Fig. 1B).
Identification of in Vitro Phosphorylation Sites on Pellino 1. To
identify the sites of Pellino 1 phosphorylation, Pellino 1 was
phosphorylated with IRAK1 (24), digested with trypsin, and
analyzed by MS (Fig. 2A) (26, 27). Diphosphorylated forms of
phospho-peptides comprising residues 73–83 and 68–83 were
identified, and the MS data were consistent with phosphoryla-
tion of any 2 of the 4 residues, Ser-76, Ser-78, Thr-80, and Ser-82
(Fig. 2B). Three other phosphorylation sites were identified as
Thr-86, Thr-127, and Thr-288 (Fig. 2B). We compared the
sequences of the 3 human Pellino isoforms, which show 80%
amino acid similarity, and Drosophila Pellino, and observed that
Ser-76, Ser-78, Thr-80, Ser-82, Thr-86 and Thr-288 were con-
served or phosphorylatable residues in all 4 species of Pellino,
but Thr-127 was not (Fig. 2C).
The removal of the GST tag from Pellino 1 by cleavage with
PreScission protease leaves a pentapeptide sequence GPLGS,
preceding the initiating methionine residue of Pellino 1. We
found that the serine in this sequence was also phosphorylated
by IRAK1 (Fig. 2), but its mutation to Ala had no effect on the
ability of IRAK1 to activate Pellino 1 (Fig. S1). All subsequent
experiments were therefore carried out with a mutant in which
this residue was changed to Ala.
To identify phosphorylated residues that were critical for
activation of Pellino’s E3 ligase activity, the 7 sites identified in
Fig. 2 were mutated to Ala both separately and in combination,
and the ability of Pellino 1 to mediate the formation of free
Lys-63-linked polyubiquitin chains in the presence of Ubc13–
Uev1a was studied. Surprisingly, even when all 7 sites (Ser-76,
Ser-78, Thr-80, Ser-82, Thr-86, Thr-127, and Thr-288) were
mutated to Ala, IRAK4 (Fig. 3, compare lanes 2 and 3) was able
to activate this form of Pellino 1 (termed Pellino 1[7A]) similarly
to wild-type Pellino 1, suggesting that an additional site(s) of
phosphorylation had been missed that was critical for activation.
Pellino 1[7A] was therefore phosphorylated by incubation with
IRAK4 and Mg-[-32P]ATP and found to incorporate 25% of
the 32P-radioactivity introduced into wild-type Pellino 1. MS
analysis of the tryptic digest as in Fig. 2 identified Ser-70 as an
additional site of phosphorylation, but Pellino 1[8A], in which
Ser-70 and the other 7 identified sites were mutated to Ala, could
also be activated by IRAK4 (Fig. 3, lane 4) similarly to wild-type
Pellino 1.
We next phosphorylated wild-type Pellino 1 and Pellino 1[8A]
with IRAK4 and Mg-[32P]ATP but, after tryptic digestion, we
used RP-HPLC to separate the 32P peptides. These experiments
revealed that the major peptide (T9) in the digest of Pellino
1[8A] (Fig. 4B) was the latest eluting of the many 32P peptides
present in the digest of wild-type Pellino 1 (Fig. 4A). MS analysis
of this fraction from both digests revealed the presence of the
same 3 phosphopeptides corresponding to amino acid residues
280–295, 273–295 and 105–136, the first of these arising from
cleavage of the Arg–Pro bond between residues 279 and 280,
which did not occur in the second peptide. Solid-phase Edman
sequencing of this fraction from wild-type Pellino 1 showed that
32P radioactivity was released from the peptides after the ninth,
16th, and 23rd cycles of Edman degradation (Fig. 5A), indicating
that phosphorylation had taken place at Thr-288 (the ninth and
16th residues of the peptides 280–295 and 273–295, respectively)
and Thr-127 (the 23rd residue in the peptide 105–136), 2 of the
sites detected earlier in this study by a different method (Fig. 2).
In contrast, solid-phase sequencing of the same fraction from the
tryptic digest of Pellino 1[8A] released 32P radioactivity after the
14th and 21st cycles of Edman degradation (Fig. 5B). These
results demonstrated that Ser-293 (the 14th and 21st residue of
the peptides 280–295 and 273–295, respectively) had become
phosphorylated now that Thr-288 was no longer available for
phosphorylation, and that Ser-125 (the 21st residue of the
peptide 105–136) had become phosphorylated now that Thr-127
was unavailable for phosphorylation. Ser-125 is replaced by an
amino acid residue that cannot be phosphorylated in Pellino 2,
Pellino 3, and Drosophila Pellino (Fig. 2C). Ser-293 is conserved
in the 3 human Pellino isoforms, although not in Drosophila
Pellino (Fig. 2C).
The results described above led us to generate a further
mutant, termed Pellino 1[10A], in which Ser-125 and Ser-293,
and the other 8 sites in Pellino 1[8A], were mutated to Ala. This
Fig. 1. The IRAK-catalyzed activation of Pellino 1 requires the phosphory-
lation of Pellino 1. (A) The E3 ubiquitin ligase activities of three different
Pellino complexes were compared by using Ubc13–Uev1a as the E2-
conjugating enzyme. Lanes 1 and 2 show the activity of a phosphorylated
IRAK1–unphosphorylated Pellino 1 complex, lanes 3 and 4 show a phosphor-
ylated IRAK1–phosphorylated Pellino 1 complex, and lanes 5 and 6 show
unphosphorylated Pellino 1 in the absence of IRAK1. The preparation of each
complex and their assay are detailed in Experimental Procedures. pUb, polyu-
biquitin. (B) GST–Pellino 1 was phosphorylated with IRAK4 (lanes 1 and 2) or
left unphosphorylated by incubation without IRAK4 (lanes 3 and 4). GST–
Pellino 1 was then freed from IRAK4 and assayed for E3 ligase activity as
described in Experimental Procedures.
Smith et al. PNAS  March 24, 2009  vol. 106  no. 12  4585
BI
O
CH
EM
IS
TR
Y
IN
A
U
G
U
RA
L
A
RT
IC
LE
mutant could hardly be activated by IRAK4 (Fig. 3, lane 5)
compared with wild-type Pellino 1 (Fig. 3, lane 2) or Pellino
1[8A] (Fig. 3, lane 4), suggesting that the key activating sites were
located within the 10 Ser/Thr residues that had been mutated.
Like the other Pellino mutants, Pellino 1[10A] retained the trace
basal activity of unphosphorylated wild-type Pellino 1, indicating
that the mutation of multiple Ser/Thr residues to Ala had not
affected the ability of Pellino 1 to function as an E3 ligase.
We also analyzed the 32P-tryptic peptides T1–T8 in the digest
of wild-type Pellino 1 (Fig. 4A). Peptides T1-T4 were found to
contain several phosphopeptides spanning the region between
amino acids 68 and 83. T1 and T2 contained triply and doubly
phosphorylated versions, respectively, of a peptide comprising
residues 73–83. Like peptide T2, peptide T3 also contained the
doubly phosphorylated derivative of the peptide comprising
residues 73–83 plus a peptide comprising residues 68–83 with 3
and 4 phosphorylated residues. Peptide T4 contained doubly and
singly phosphorylated forms of the peptide 73–83 and a doubly
phosphorylated version of the peptide comprising residues 68–
83. Solid-phase sequencing of phosphopeptides T1–T4 was con-
sistent with phosphorylation taking place at Ser-76, Ser-78,
Thr-80, and Ser-82 (Fig. S2A). Peptide T5 contained the peptide
84–104 phosphorylated at Thr-86 and the peptide 280–295
phosphorylated at both Thr-288 and Ser-293. T6 contained a
diphosphorylated version of the peptide 273–295, phosphory-
lated at both Thr-288 and Ser-293, and a monophosphorylated
version of the peptide 280–295. Peptide T7 also contained the
peptide 273–295 but phosphorylated at Thr-288 alone, plus the
peptide comprising residues 280–295 phosphorylated at Thr-288
and the peptide comprising 105–136. Peptide T8 also contained
a monophosphorylated form of the peptide 273–295, which was
phosphorylated at Thr-288, and the peptide 280–295, which
was phosphorylated at both Thr-288 and Ser-293. Thus, the
major phosphopeptides detected in this analysis were consistent
with the results obtained in Fig. 2, but identified the precise sites
of phosphorylation more definitively (Table S1A).
Comparison of the Sites Phosphorylated by IRAK1 and IRAK4. The
pattern of phosphopeptides detected after RP-HPLC of tryptic
digests of Pellino 1 phosphorylated by IRAK1 (Fig. 4C) was
similar to that observed after phosphorylation by IRAK4 (Fig.
4A) and was further confirmed by solid-phase sequencing
of phosphopeptides T1 to T4 (Fig. S2B). IRAK1 did, how-
ever, appear to phosphorylate Thr80 preferentially to Ser82
Fig. 2. Identification of phosphorylation sites in Pellino 1 by LC/MS. (A) Pellino 1 was phosphorylated by IRAK1 in vitro and subjected to SDS/PAGE, and the band
corresponding tophosphorylatedPellino1was excised, digestedwith trypsin, andanalyzedby LC/MSwithprecursor of 79 scanning (27). (B) Identificationof themajor
peaks in A. Phosphorylated residues are shown in bold, andmethionine sulfoxide is indicated byM*. The first 5 residues of phosphopeptides 3a and 3b, precede the
initiatingmethionine (M) of Pellino 1 for reasons explained in Results. (C) Comparison of the amino acid sequences surrounding the identified phosphorylation sites
in human and Drosophila Pellinos. The major sites of IRAK1/4-catalyzed phosphorylation identified in this study are denoted by *. The white letters on a black
background indicate identities between the sequences and black letters on a gray background indicate conservative replacements.
1     2     3     4    5    6
pUb
Lane
Fig. 3. Activation of wild-type and mutant forms of Pellino 1 by IRAK4 in
vitro. Pellino 1was phosphorylatedwith (lanes 2–6) orwithout (lane 1) IRAK4,
and its E3 ligaseactivitywasmeasuredwithUbc13-Uevla for 3minasdescribed
in Experimental Procedures. Lanes 1 and 2, wild-type Pellino 1; lane 3, Pellino
1[7A]; lane 4, Pellino 1[8A]; lane 5, Pellino 1[10A]; lane 6, Pellino 1[10A] in
which Ala-125 and Ala-127were back-mutated to Ser and Thr, respectively. In
Pellino 1[7A] residues 76, 78, 80, 82, 86, 127, and 288 all were mutated to Ala.
Pellino 1[8A] contained the same mutations as Pellino 1[7A] except for the
further mutation of Ser-70 to Ala. Pellino 1[10A] contained the same muta-
tions as Pellino 1[8A] except for the further mutation of Ser-125 and Ser-293
to Ala (see Fig. 2C for the amino acid sequences of these regions).
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and the region comprising amino acid residues 105–136 (con-
taining Ser-125 and Thr-127) much more weakly than IRAK4
(Table S1B).
Identification of Amino Acid Residues Whose Phosphorylation Acti-
vates Pellino 1. To identify which phosphorylation sites were
critical for activation, we back-mutated particular Ala residues in
Pellino 1[10A] to the Ser or Thr residues present in wild-type
Pellino 1. Like Pellino 1, Pellino 2 and Pellino 3 can be activated
by IRAK1 and IRAK4 in vitro (23, 24), but Ser-125 and Thr-127
are not present in these isoforms (Fig. 2C). For this reason, it
seemed unlikely that they would be the key activating sites and
so Ala-125 and Ala-127 were initially reconverted to Ser and
Thr, respectively, while keeping all of the other phosphorylation
sites as Ala residues. This mutant could not be activated by
IRAK4 in vitro (Fig. 3, lane 6), demonstrating that activation could
not be achieved by the phosphorylation of Ser-125 and/or Thr-127
alone.
We next restored amino acid residues 288 and/or 293 to Thr
and Ser, respectively. These experiments revealed that the
reconversion of residue 288 to Thr and/or residue 293 to Ser was
sufficient to restore activation to a level similar to that observed
with wild-type Pellino 1, even when all of the other 8 sites were
unavailable for phosphorylation (Fig. 6A, compare lanes 4–6
with lanes 2 and 3). However, Pellino 1 in which both Thr-288
and Ser-293, but no other residue, had been mutated to Ala
could also be activated by IRAK4 (Fig. 6A, lane 7). This result
indicated that phosphorylation of one or more of the Ser and Thr
residues between Ser-70 and Thr-86 was also sufficient for
activation if neither Thr-288 nor Ser-293 was available for
phosphorylation.
To identify other residues whose phosphorylation was capable
of activating Pellino 1 we back-mutated Pellino 1[10A] to restore
residue 76 to Ser, or residue 78 to Ser, or residue 80 to Thr, or
residue 82 to Ser, or residue 86 to Thr. These experiments
revealed that the back-mutation of residue 76 alone to Ser was
sufficient to restore activation by IRAK4 (Fig. 6B, lane 4) to a
level similar to that observed with wild-type Pellino 1. The back
mutation of residue 86 to Thr alone allowed partial activation by
IRAK4 (Fig. 6B, lane 8), but the individual back mutation of
residue 78 or residue 80 or residue 82 did not by themselves
permit any activation by IRAK4 (Fig. 6B, lanes 5–7). However,
when residues 78, 80, and 82 or residues 78, 80, 82, and 86 were
back-mutated to Ser or Thr in combination, while keeping residues
76, 125, 127, 288, and 293 as Ala, these species could also be
activated by IRAK4 (Fig. 6B, lanes 9 and 10) similarly to wild-type
Pellino 1.
Thr-290 of Pellino 2 Is Phosphorylated in Cells. To investigate
whether Pellino was phosphorylated in cells at a residue critical
for activation, we raised a phospho-specific antibody that rec-
ognizes Pellino 1 phosphorylated at Thr-288 and also recognizes
Pellino 2 phosphorylated at the equivalent residue (Thr-290).
The cotransfection of Pellino 2 with wild-type IRAK1 in
IRAK1-null IL-1R cells led to the phosphorylation of Pellino 2
at Thr-290, but this did not occur if wild-type IRAK1 was
replaced with a catalytically-inactive mutant (Fig. 6C). Pellino 2
was used in this experiment instead of Pellino 1, because Pellino
1 was difficult to express in these cells.
Effect of Phosphorylation on the E3 Ligase Activity of Pellino 1 with
Different E2-Conjugating Complexes. In the experiments described
above, the activity of Pellino 1 was studied in vitro by using the
E2-conjugating enzyme Ubc13–Uev1a with which it forms free
Lys-63-linked polyubiquitin chains not attached to any other
protein. However, we have reported that Pellino 1 can form
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Fig. 4. Separation of tryptic phosphopeptides from Pellino 1. 32P-labeled
Pellino 1 obtained by incubation with Mg-[32P]ATP and either IRAK4 (A and
B) or IRAK1 (C)was subjected to SDS/PAGE, thegelwas stainedwithCoomassie
blue, and Pellino 1 was excised, digested with trypsin, and subjected to
RP-HPLC on a Vydac C18 column equilibrated in 0.1% (vol/vol) trifluoroacetic
acid. The columnwasdevelopedwithanacetonitrile gradient in 0.1%(vol/vol)
trifluoroacetic acid. 32P radioactivity in arbitrary units (au) is shown by the full
line, and the acetonitrile gradient is indicated by the diagonal broken lines. (A
and C) Wild-type Pellino 1. (B) Pellino 1[8A].
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Fig. 5. Solid-phase sequencing of peptide T9 from Fig. 4. Peak T9 from
wild-type Pellino 1 (Fig. 4A) and Pellino 1[8A] (Fig. 4B) were subjected to
solid-phase sequencing (36) to identify the cycles of Edman degradation at
which 32P radioactivity (filled bars) was released from the phosphopeptides
present in these fractions.
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polyubiquitin chains of different topology when incubated with
other E2-conjugating complexes. For example, when incubated
with UbcH4 or UbcH5a/5b the polyubiquitin chains formed were
mainly linked via Lys-11 and Lys-48 of ubiquitin (24). Moreover,
in contrast to the free Lys-63-linked polyubiquitin chains formed
with Ubc13–Uev1a, the polyubiquitin chains formed with
UbcH4/5a/5b are conjugated to IRAK1 and Pellino (24). It was
therefore important to know whether the phosphorylation of
Pellino 1 also increased its E3 ubiquitin ligase activity when
assayed with E2s other than Ubc13–Uev1a. These experiments
revealed that the phosphorylation of Pellino 1 also greatly
enhanced its activity with UbcH5a, UbcH5b, and UbcH4 (Fig.
7). After tryptic digestion and analysis by MS, we identified
Lys-355 and Lys-397 in IRAK1 and Lys-169, Lys-202, and
Lys-266 of Pellino 1 as amino acid residues that became conju-
gated to ubiquitin in the presence of UbcH4 in vitro (Fig. S3).
The failure to detect Lys-134 and Lys-180 of IRAK1 was
initially surprising as their polyubiquitination was reported to be
critical for signaling ‘‘downstream’’ of IRAK1 (9). However,
inspection of the sequence of IRAK1 revealed that Lys-134 and
Lys-180 should both be present in a single 75-residue tryptic
peptide. The large size of this peptide probably explains the
failure to detect it in MS analysis.
Discussion
In this article we demonstrate that Pellino 1 is phosphorylated
at multiple sites by IRAK1 or IRAK4 in vitro. The key residues
involved in activation are located between residues 76 and 86
(Ser-76, Ser-78, Thr-80, Ser-82, and Thr-86) and at Thr-288 and
Ser-293, just N-terminal to the RING-like domain that carries
the E3 ligase activity. Unusually, we found that the phosphor-
ylation of Ser-76 or Thr-288 or Ser-293 alone was sufficient for
maximal activation, under the assay conditions that we studied,
whereas phosphorylation of Thr-86 alone caused partial activa-
tion, even when all of the other phosphorylation sites were
mutated to Ala. Moreover, if Ser-76, Thr-86, Thr-288, and
Ser-293 all were mutated to Ala, full activation by IRAK1 or
IRAK4 could still occur if Ser-78, Thr-80, and Ser-82 were
available for phosphorylation (Fig. 6). All of these sites are
conserved in Pellino 2 and 3 and in Drosophila Pellino, apart
from Thr-86, which is Ser in Pellino 3 and Ala in Drosophila
Pellino (Fig. 2C). Moreover, because Pellino 2 and Pellino 3 can
also be activated by IRAK1/IRAK4, these observations imply
that all forms of Pellino are likely to be activated by a common
mechanism. A key outstanding question is whether IRAK1,
IRAK4, or both protein kinases mediate the activation of Pellino
isoforms in vivo.
The finding that Pellino 1 (and presumably other Pellino
isoforms) can be activated by the phosphorylation of several
different sites, or sets of sites, implies that the dephosphorylation
of multiple residues is needed before any decrease in the E3
ligase activity of Pellino could occur. This may be a device for
maintaining the activation of Pellino isoforms and prolonging
the Lys-63-linked polyubiquitination of IRAK1. This situation is
unusual, although it is reminiscent of the phosphorylation of
mitogen-activated protein kinase kinase 1 (MKK1) by c-Raf,
where the phosphorylaton of either Ser-218 or Ser-222 is suffi-
cient for activation, and dephosphorylation of both sites is
needed for inactivation (28). Similarly, the activity of glycogen
synthase can be decreased by phosphorylating different sets of
serine residues, although in this case distinct protein kinases
phosphorylate the different sites (29).
While this study was in progress, the 3D structure of Pellino
2 (but lacking the C-terminal RING-like domain) was solved by
X-ray crystallography (30). These studies unexpectedly revealed
Fig. 6. Activation of different mutants of Pellino 1. Wild-type and mutated
forms of Pellino 1 were phosphorylated with (lanes 2–7) or without (lane 1)
IRAK4, and their E3 ligase activity was measured for 3 min as described in
Experimental Procedureswith Ubc13-Uevla. Pellino 1[10A] is a form of Pellino
1 in which the 10 phosphorylation sites at residues 70, 76, 78, 80, 82, 86, 125,
127, 288, and 293 are all mutated to Ala. (A) Lanes 1 and 2, wild-type Pellino
1; lane 3, Pellino 1[10A] inwhich Ala-125 andAla-127 had been back-mutated
to Ser and Thr, respectively; lane 4, same as lane 3, except for the additional
back mutation of Ala-288 to Thr; lane 5, same as lane 3 except for the
additional backmutation of Ala-293 to Ser; lane 6, same as lane 3, except that
both Ala-288 and Ala-293 were back-mutated to Thr and Ser, respectively;
lane 7, Pellino 1 in which Thr-288 and Ser-293 (but no other residue) was
mutated to Ala. (B) Lanes 1 and 2, wild-type Pellino 1; lane 3, Pellino 1[10A] in
which Ala-125 and Ala-127 were back-mutated to Ser and Thr, respectively;
lanes 4, 5, 6, 7, and8 showtheactivities of Pellino1[10A] inwhichAla-76alone,
Ala-78 alone, Ala-80 alone, Ala-82 alone, or Ala-86 alone, respectively were
back-mutated to the Ser or Thr present in wild-type Pellino 1; lane 9, Pellino
1[10A] in which Ala-78, Ala-80, and Ala-82 were backmutated to Ser, Thr, and
Ser, respectively; lane 10, Pellino 1[10A] in which Ala-78, Ala-80, Ala-82, and
Ala-86 were back-mutated to Ser, Thr, Ser, and Thr, respectively. (C) DNA
vectors encoding HA-Pellino 2 and either wild-type flag–IRAK1 (lane 1) or the
catalytically-inactive flag–IRAK1[K239A] mutant (lane 2) were cotransfected
into IRAK1-null IL-1R cells. Twenty-four hours later the cells were lysed and 25
g of extract protein was subjected to SDS/PAGE and immunoblotted with a
phospho-specific antibody that recognizes Thr-288 of Pellino 1 and the equiv-
alent residue in Pellino 2 (Thr-290). NS, nonspecific band recognized by the
antibody.
Fig. 7. Effect of phosphorylation of Pellino 1 on its E3 ligase activity in the
presence of different E2-conjugating enzymes. Pellino 1 was phosphorylated
by incubation for30minat30 °Cwithout (lanes1–3)orwith (lanes4–6) IRAK4,
and its E3 ligase activity then measured for the times indicated by using
UbcH5a (Top), UbcH5b (Middle), or UbcH4 (Bottom) as the E2-conjugating
enzyme (see Experimental Procedures). pUb, polyubiquitin.
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the presence of a ‘‘cryptic’’ Forkhead-associated (FHA) domain
formed by several disparate regions of Pellino 2. The cluster of
phosphorylation sites between amino acid residues 76 and 86
decorate a region of antiparallel -sheet that forms an append-
age or wing of the FHA domain (Fig. 8). The presented structure
terminates at residue 258 of Pellino 2, so that residues 288 and
293 of Pellino 1 (equivalent to residues 290 and 295 of Pellino 2),
which are located just before the RING domain, are not present,
but are clearly not situated within the FHA domain. FHA
domains are known to bind to phosphothreonine-containing
peptides, and one role of this domain in Pellino could be to bind
the autophosphorylated form of IRAK1. Such an interaction
might facilitate the IRAK1-catalyzed phosphorylation Pellino or
position IRAK1 in such a way that it can be polyubiquitinated
efficiently by Pellino–E2 complexes. Interestingly, 2 of the lysine
residues in Pellino 1 that underwent autopolyubiquitination in
vitro upon incubation with UbcH4, namely Lys-169 and Lys-202
(equivalent to Lys-171 and Lys-204 of Pellino 2), are located in
insertions that loop out from the wing and the FHA domain,
respectively (Fig. 8). The third lysine (Lys-266 of Pellino 1/Lys-
268 of Pellino 2) is located C-terminal to the fragment of Pellino
2 whose structure was presented (30).
The E2-conjugating enzyme Ubc13–Uev1a appears to play a
key role in directing the formation of Lys-63-linked polyubiquitin
chains in vivo. However, the observation that Ubc13–Uev1a only
catalyzes the formation of free Lys-63-linked polyubiquitin
chains when incubated in vitro with E3 ligases, such as TRAF6,
CHIP (31), or Pellino 1 (24, 25), raises the question of how
Lys-63-linked polyubiquitin chains actually become conjugated
to proteins in vivo, because the cotransfection of Pellino with
IRAK1 leads to the formation of Lys-63-linked polyubiquiti-
nated IRAK1 in cells (24). The most likely explanation for this
discrepancy is that a second E2-conjugating enzyme, distinct
from Ubc13–Uev1a, is required to attach the first ubiquitin
moiety to IRAK1, whereas Pellino–Ubc13–Uev1a complexes
promote the elongation of the monoubiquitinated species. In-
deed, in budding yeast, there is strong genetic evidence that
proliferating cell nuclear antigen (PCNA), a key protein in the
DNA repair pathway, is monoubiquitinated by the E2-
conjugating enzyme RAD6 and the E3 ligase RAD18 and then
Lys-63-polyubiquitinated by the E2-conjugating enzyme Ubc13–
Mms2 and the E3 ligase RAD5 (32). Similarly, the Lys-63-linked
polyubiquitination of MHC class 1 molecules in HeLa cells
mediated by the K3 gene product of Karposi’s sarcoma herpes
virus involves UbcH5b/c mediated monoubiquitination followed
by Ubc13-dependent Lys-63-linked polyubiquitination (33). A
2-step model for Lys-48-linked polyubiquitination has also been
proposed for the anaphase-promoting complex in yeast, with
UbcH4 promoting monoubiquitination and Ubc1, the yeast
homologue of the human E2 25K protein, promoting chain
extension (34). It therefore seems likely that a similar situation
occurs in the innate immune system, with themonoubiquitnation
of IRAK1 being catalyzed by an E2 distinct from Ubc13–Uev1a.
It was recently reported that IL-1 also stimulated the Lys-48-
linked polyubiquitination of IRAK1 in IL-1R cells. However, in
contrast to the rapid Lys-63-linked polyubiquitination of
IRAK1, which was detected at 5 min and was maximal between
30 and 60 min (13), Lys-48-linked polyubiquitination of IRAK1
was much slower, peaking between 90 and 150 min. Whether a
Pellino isoform mediates the slow Lys-48-linked polyubiquitina-
tion of IRAK1 in conjunction with an E2-conjugating enzyme
distinct from Ubc13–Uev1a, is unknown. We have reported that
Pellino participates in the formation of Lys-48-linked polyubiq-
uitin chains when incubated with UbcH3 in vitro (24), but
additional experiments have shown that this results from the
UbcH3-catalyzed formation of free Lys-48-linked polyubiquitin
chains, without any contribution from Pellino 1.
In summary, the results presented here, together with the work
of other laboratories, suggest the following model by which IL-1
may stimulate the Lys-63-linked polyubiquitination of IRAK1.
In this model, the interaction of IL-1 with its receptor first
recruits MyD88, IRAK4, and IRAK1. IRAK4 then activates
IRAK1 followed by the autophosphorylation of IRAK1 at
multiple sites. This causes the dissociation of IRAK1 and IRAK4
from MyD88 and phosphorylated IRAK1 to bind to the FHA
domain of Pellino. IRAK1 and/or IRAK4 then catalyze the
phosphorylation of Pellino, followed by a 2-step process in which
activated Pellino first combines with an E2, distinct fromUbc13–
Uev1a tomonoubiquitinate IRAK1 and then with Ubc13–Uev1a
to produce Lys-63-linked polyubiquitinated IRAK1. However,
the involvement of other E3 ligases, such as TRAF6 (9), in the
attachment of the first or subsequent ubiquitins to IRAK1 is not
excluded. Further work is therefore needed to identify all of the
E3 ligases and E2-conjugating enzymes involved in the polyu-
biquitination of IRAK1.
Experimental Procedures
DNA Constructs. DNA and expression vectors have been described (24). Mu-
tations were made following the QuikChange site-directed mutagenesis
method (Stratagene), but using KOD Hot Start Polymerase.
Protein Expression and Purification. Pellino 1 was expressed as a GST-fusion
protein in Escherichia coli with a PreScission protease cleavage site between
the GST and the Pellino 1. The GST tag was removed by cleavage with
PreScission protease as described (24), which leaves a sequence of 5 amino
acids before the normal initiating methionine residue of Pellino 1. Pellino 1
that had been freed from GST in this way was used for all experiments unless
specified otherwise. IRAK1 and IRAK4 were expressed as active GST-tagged
proteins in insect Sf21 cells and purified on glutathione-Sepharose, whereas
IRAK4 was also expressed with a His6 tag at its N terminus instead of GST and
purified on nickel-nitrilo-triacetate agarose. The E2-conjugating enzymes
UbcH4, UbcH5a, and UbcH5bwere produced as His6-tagged proteins in E. coli
and purified on nickel nitrilotriacetate agarose (24), and the E2-conjugating
complex Ubc13–Uev1a and E1 enzyme were produced as described (35).
Ubiquitin was purchased from Sigma.
Antibodies. A synthetic phosphopeptide CPVGFNT*LAFPS (corresponding to
residues 282–293 of Pellino 1, where T* is phosphothreonine) was conjugated
to both keyhole limpet hemocyanin and BSA and injected into a sheep (sheep
S393C). The serum from the third bleed was affinity-purified against the
phosphopeptide antigen that had been immobilized on agarose, and the
purified antibody was used for immunoblotting at 1 g/mL in the presence of
10 g/mL of the unphosphorylated form of the immunogen. Antiubiquitin
was purchased from DakoCytomation, and anti-rabbit IgG was from Pierce.
S76
S78
T80
S82
T86
FHA domain wing appendage
K169
K202
Fig. 8. Location of the N-terminal phosphorylation sites and autoubiquiti-
nation sites in the structure of Pellino 1. A homology model of Pellino 1 was
generatedbasedon the recently published structure of Pellino 2 (30) using the
program Modeller (37). Ser-76, Ser-78, Thr-80, Ser-82, and Thr-86 of Pellino 1
(shown in red) are located in a region of antiparallel -sheet, termed thewing
(turquoise), which is an appendage of the cryptic FHA domain (blue) thought
to interactwith phosphorylated IRAK1. Lys-169 and Lys-202of Pellino 1,which
were detected as sites of autoubiquitination, are also shown in red.
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Preparation of Different Pellino-1–IRAK1 Complexes.A phosphorylated IRAK1–
phosphorylated Pellino 1 complex was prepared by incubating IRAK1 (1 M)
with Pellino 1 (1 M) for 30 min at 30 °C in 50 mM TrisHCl (pH 7.5), 5 mM
MgCl2, and 2 mM ATP. After 30 min IRAK1 was inhibited by adding stauro-
sporine to a final concentration of 75 M. A phosphorylated IRAK1–
unphosphorylated Pellino 1 complex was prepared by incubating IRAK1 with
MgATPas described above andonly adding Pellino 1 after the IRAK1hadbeen
inactivated with staurosporine. Unphosphorylated Pellino 1 was prepared by
taking it through the same procedure in the absence of IRAK1.
Removal of IRAK4 from Pellino. GST–Pellino 1 (1 M)was incubated for 30 min
at 30 °C in 50mMTrisHCl (pH 7.5), 5mMMgCl2, and 2mMATP in the presence
or absence of His6-IRAK4 (1M). After 30min at 30 °C, glutathione-Sepharose
(5 L of packed volume) was added and the reactions kept on ice for 45 min
with occasionally stirring. After brief centrifugation to pellet the glutathione
Sepharose towhich the GST–Pellinowas nowbound, the pellets werewashed
3 times with 1 mL of 50 mM TrisHCl (pH 7.5), 0.5 M NaCl and 3 times with 50
mM TrisHCl (pH 7.5).
Assay of the E3 Ligase Activity of Pellino 1. The assays of Pellino 1 (1 M) were
carried out in 20-L incubations with E1 enzyme (0.1 M), E2-conjugating
enzyme (1 M), ubiquitin (0.1 mM), magnesium chloride (5 mM), ATP (2 mM),
and IRAK1/4 where indicated (1 M) in 50 mM TrisHCl (pH 7.5) at the final
concentrations indicated in parentheses. The reactions were terminated by
denaturation in SDS, subjected to SDS/PAGE, transferred tonitrocellulose, and
immunoblotted with antiubiquitin.
Analysis of Phosphorylation and Ubiquitination by MS. Phosphorylated and
ubiquitinated proteins were separated by SDS/PAGE, stained with Colloidal
Coomassie blue and digested with trypsin as described (26). When the sites of
phosphorylation could not be assigned from the MS/MS spectra acquired on
the 4000 Q-Trap, a second aliquot of the digest was analyzed by LC-MS with
multistage activation on a ThermoElectron LTQ-orbitrap system coupled to a
Dionex 3000 HPLC system. The resultant MS/MS spectra were searched by
using Mascot (Matrixscience) run on a local server, allowing for phospho-
serine/phosphothreonine, phosphotyrosine, and Gly–Gly attached to a ubi-
quitinated lysine residue as revealed by an enhanced mass of 114.1 Da. The
mass tolerances used were/ 1Da for 4000 Q-Trap experiments and/ 20
ppm for orbitrap experiments.
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